Get started
Author

Michael Strupp

Observed names: M Strupp, M. Strupp, Strupp, Michael
Observed institutions: Universidade de São Paulo, Universität Ulm, German Center for Neurodegenerative Diseases, LMU Klinikum, Essen University Hospital, München Klinik, Bernstein Center for Computational Neuroscience Munich, Hertie Institute for Clinical Brain Research, National Hospital for Neurology and Neurosurgery, Fritz Bauer Institut, UCL Queen Square Institute of Neurology, Institut für Medizinische Informationsverarbeitung, Biometrie und Epidemiologie, Deutsches Schwindel- und Gleichgewichtszentrum, University College London, University of Duisburg-Essen, Charité - Universitätsmedizin Berlin, University of Tübingen, Ludwig-Maximilians-Universität München
OpenAlex ID: A5111067623
Treatment of episodic ataxia type 2 with the potassium channel blocker 4-aminopyridine
2004 · M. Strupp, R. Kalla, et al. · Neurology · 253
A randomized trial of 4-aminopyridine in EA2 and related familial episodic ataxias
2011 · M. Strupp, R. Kalla, et al. · Neurology · 211
PDF
Episodic Ataxia Type 2
2007 · Michael Strupp, Andreas Zwergal, et al. · Neurotherapeutics · 198
PDF
Consensus Paper: Management of Degenerative Cerebellar Disorders
2013 · W. Ilg, A. J. Bastian, et al. · The Cerebellum · 196
Natural History, Phenotypic Spectrum, and Discriminative Features of Multisystemic RFC1 Disease
2021 · Andreas Traschütz, Andrea Cortese, et al. · Neurology · 166
PDF
Therapie und Verlauf neurologischer Erkrankungen
2017 · Benedikt Schoser, Jörg B. Schulz, et al. · 135
A multicenter observational study on the role of comorbidities in the recurrent episodes of benign paroxysmal positional vertigo
2013 · Alessandro De Stefano, Francesco Dispenza, et al. · Auris Nasus Larynx · 127
PDF
4-Aminopyridine restores vertical and horizontal neural integrator function in downbeat nystagmus
2007 · R. Kalla, S. Glasauer, et al. · Brain · 125
Cerebellar ataxias: an update
2019 · Mario Manto, Jordi Gandini, et al. · Current Opinion in Neurology · 100
GAA-FGF14 disease: defining its frequency, molecular basis, and 4-aminopyridine response in a large downbeat nystagmus cohort
2024 · David Pellerin, Felix Heindl, et al. · EBioMedicine · 72
PDF
Therapie und Verlauf neurologischer Erkrankungen
2023 · Benedikt Schoser, Jörg B. Schulz, et al. · 68
Episodic Ataxia Type 1 and 2 (Familial Periodic Ataxia/Vertigo)
1997 · Thomas Brandt, Michael Strupp · Audiology and Neurotology · 62
Fampridine and Acetazolamide in EA2 and Related Familial EA
2020 · Carolin Muth, Julian Teufel, et al. · Neurology Clinical Practice · 54
False-Positive Head-Impulse Test in Cerebellar Ataxia
2012 · Olympia Kremmyda, Hanni Kirchner, et al. · Frontiers in Neurology · 52
PDF
4-Aminopyridine improves gait variability in cerebellar ataxia due to CACNA 1A mutation
2011 · Roman Schniepp, Max Wuehr, et al. · Journal of Neurology · 46
IntronicFGF14GAA repeat expansions are a common cause of ataxia syndromes with neuropathy and bilateral vestibulopathy
2023 · David Pellerin, Carlo Wilke, et al. · Journal of Neurology Neurosurgery & Psychiatry · 45
PDF
Safety and Efficacy of Acetyl-DL-Leucine in Certain Types of Cerebellar Ataxia
2021 · Katharina Feil, Christine Adrion, et al. · JAMA Network Open · 42
PDF
Role of the repeat expansion size in predicting age of onset and severity in RFC1 disease
2024 · Riccardo Currò, Natalia Dominik, et al. · Brain · 37
PDF
Consensus Paper: Strengths and Weaknesses of Animal Models of Spinocerebellar Ataxias and Their Clinical Implications
2021 · Jan Cendelin, Marija Cvetanovic, et al. · The Cerebellum · 35
Effects of dalfampridine on attacks in patients with episodic ataxia type 2: an observational study
2012 · Jens Claassen, Julian Teufel, et al. · Journal of Neurology · 35
The Clinical Spectrum of Autosomal‐Dominant Episodic Ataxias
2014 · Stefan Kipfer, Michael Strupp · Movement Disorders Clinical Practice · 31
PDF
Effects of acetyl-DL-leucine on cerebellar ataxia (ALCAT trial): study protocol for a multicenter, multinational, randomized, double-blind, placebo-controlled, crossover phase III trial
2017 · Katharina Feil, Christine Adrion, et al. · BMC Neurology · 25
PDF
Dysfunction of the brain calcium channel CaV2.1 in absence epilepsy and episodic ataxia—a comment
2005 · Michael Strupp, Roger Kalla, et al. · Brain · 16
Intronic FGF14 GAA repeat expansions are a common cause of ataxia syndromes with neuropathy and bilateral vestibulopathy
2023 · David Pellerin, Carlo Wilke, et al. · Journal of the Neurological Sciences · 13
PDF
RFC1 repeat expansions in downbeat nystagmus syndromes: frequency and phenotypic profile
2024 · David Pellerin, Felix Heindl, et al. · Journal of Neurology · 12
PDF
Works count: 53
Citation count: 2,220
H-index: 22
I10-index: 27
Year
Topic
Type